Mark Cusack Email & Phone Number

Oxford, GB

London Area, United Kingdom

Furthr is the benefit of climate feel-good!Each month, our subscribers plant protected trees and reduce carbon emissions on world-leading climate projects. As a reward, each of our subscribers has the chance of winning prizes in our exciting monthly prize draws, with experiences, cash & eco goodies up for grabs!Our trees restore wildlife habitats and.

Having invested in and successfully exited Logos Technologies at the end of their earn out, as a result of delivering rapid profitable growth, I am now using that experience to consult and work with start up and scale up disruptive digital and eclinical businesses to bring them to market. Using my strong pedigree in Business Development and General.

ECC/Yellow Collective was built on my initial vision to transform the built environment into ‘trees’ by a daylight activated coating that was CO2 reducing, pollution busting and pathogen killing. I founded the company, built the team, raised investment and won the first deal with a global engineering firm, influencing heavily at C-suite and project managed.

United Kingdom

I founded Environmental Control Coatings to research and develop a range of proprietary technologies to combat both internal and external air pollution. This is done by accelerating natural processes and destroying the pollution for the benefit of both the environment & human health. Initial focus has been on protective photocatalytic coatings, with our.

UK

Reporting directly to CEO, responsible for P&L of the Clinical Business Unit of Instem PLC. Responsible for the strategic & commercial development of the ALPHADAS proposition. Leading the re-generation of the software development process & code update as well as the integration of the former Logos Technologies Business Unit into the parent PLC.· Led.

UK

Responsible for Global Sales & Commercial Development of ALPHADAS, the worlds leading early phase eSource EDC.Responsible for stabilising & growing Logos Technologies in key markets globally· Worked extensively with CEO to successfully resolve initial corporate challenges regarding ownership· Worked in partnership with CEO to secure sale to Instem PLC·.

UBC acquired CDR in August 2009· Only member of global BD team of 9 to remain in post after CDR’s acquisition by UBC· Responsible for managing, developing & leveraging relationships within existing pharma and biotech clients to identify new business opportunities globally· Trained existing salesforce in the CDR product and science behind it (300+ peer.

Business Development and Marketing Strategy for CDR across existing and new accounts - within Europe, India, Japan, South Africa and the US.Responsible for growing CDR into new areas geographically, therapeutically and into later phase trials, whilst developing current client base and expanding traditional areas of strength · Won largest program of studies.

Late Phase Clinical Trials Business Development, account base within EuropeResponsible for sourcing, developing and winning Full Service Clinical Trials from client base varying from ‘virtual’ to large Pharma & Biotech · Key achievements:· Won £2 million from 5 clinical trials and various stand alone service contracts· Developed pipeline of over £7 million.

Business Development and Marketing Execution

Business Development and Marketing Strategy and execution for a new media company with exclusive online rights of the National Union of Students.

Sold Branded beers to the free on trade in London

Observed and regulated the open outcry pits of the London International Financial Futures Exchange

Bsc (Hons), Business Economics With Computing

Activities and Societies: Rugby Club, student newspaper Sports Editor, performer with the Gilbert & Sullivan Society (West Side Story.

Education record